Source: SEC

Enrich Therapeutics received $750K in Debt Funding

Read full article »

Enrich Therapeutics's Competitors | Enrich Therapeutics's News | Enrich Therapeutics's Financials

Followers on Owler

14

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Dong Wang's photo - Co-Founder & CEO of Enrich Biosystems

Co-Founder & CEO

Dong Wang

CEO Approval Rating

90/100

Enrich Therapeutics is a Connecticut-based medical device company that develops and supplies cell discovery systems for the life sciences industry.